(firstQuint)Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer.

 This study, TH-CR-301, is a Phase 1/2 study that will evaluate the efficacy and safety of glufosfamide in combination with gemcitabine in advanced solid tumors or in first line treatment of pancreatic cancer.

 Study Hypothesis: Glufosfamide in combination with gemcitabine may provide benefits in survival to patients with advanced solid tumors or metastatic pancreatic cancer.

.

 Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer@highlight

The purpose of this study is to determine the safety of glufosfamide when administered in combination with gemcitabine.

